Regulation of Embryonic Stem Cell Self-renewal by
Phosphoinositide 3-Kinase-dependent Signaling*
Received for publication, June 10, 2004, and in revised form, August 20, 2004
Published, JBC Papers in Press, August 24, 2004, DOI 10.1074/jbc.M406467200
Nicholas R. D. Paling‡, Helen Wheadon‡§, Heather K. Bone, and Melanie J. Welham¶
From the Department of Pharmacy and Pharmacology, Centre for Regenerative Medicine, University of Bath,
Claverton Down, Bath BA2 7AY, United Kingdom
The maintenance of murine embryonic stem (ES) cell
self-renewal is regulated by leukemia inhibitory factor
(LIF)-dependent activation of signal transducer and activator
of transcription 3 (STAT3) and LIF-independent
mechanisms including Nanog, BMP2/4, and Wnt signaling.
Here we demonstrate a previously undescribed role
for phosphoinositide 3-kinases (PI3Ks) in regulation of
murine ES cell self-renewal. Treatment with the reversible
PI3K inhibitor, LY294002, or more specific inhibition
of class IA PI3K via regulated expression of dominant
negative ⌬p85, led to a reduction in the ability of
LIF to maintain self-renewal, with cells concomitantly
adopting a differentiated morphology. Inhibition of
PI3Ks reduced basal and LIF-stimulated phosphorylation
of PKB/Akt, GSK3␣/␤, and S6 proteins. Importantly,
LY294002 and ⌬p85 expression had no effect on LIFinduced
phosphorylation of STAT3 at Tyr705
, but did
augment LIF-induced phosphorylation of ERKs in both
short and long term incubations. Subsequently, we demonstrate
that inhibition of MAP-Erk kinases (MEKs) reverses
the effects of PI3K inhibition on self-renewal in a
time- and dose-dependent manner, suggesting that the
elevated ERK activity observed upon PI3K inhibition
contributes to the functional response we observe. Surprisingly,
upon long term inhibition of PI3Ks we observed
a reduction in phosphorylation of ␤-catenin, the
target of GSK-3 action in the canonical Wnt pathway,
although no consistent alterations in cytosolic levels of
␤-catenin were observed, indicating this pathway is not
playing a major role downstream of PI3Ks. Our studies
support a role for PI3Ks in regulation of self-renewal
and increase our understanding of the molecular signaling
components involved in regulation of stem cell fate.
Murine embryonic stem cells, derived from the inner cell
mass of preimplantation embryos (1, 2), are pluripotent, retaining
the ability to differentiate into cells of all three germ layers
of the developing mouse embryo. The pluripotency of stem cells
relies on their ability to self-renew, and the cytokine leukemia
inhibitory factor (LIF)1
has been shown to be important for
maintaining the pluripotency of murine ES cells (3, 4). LIF
signals through a heteromeric receptor, comprised of gp130 and
the low affinity LIF receptor, to induce activation of STAT3,
which has been shown by several groups to play an essential
role in maintaining self-renewal (5–8). LIF also induces activation
of a number of additional signaling proteins, including
ERKs (9, 10), ribosomal S6 kinases (11), cyclic AMP response
element-binding proteins (11), and Src family tyrosine kinases
(12). The activation of ERKs appears to promote differentiation
(9) and has led to the suggestion that the balance between
LIF-induced STAT3 and ERK signals is important in determining
the fate of a dividing undifferentiated ES cell (13). The Src
family of tyrosine kinases appears to play a role in maintaining
self-renewal (12).
Recently, a number of publications have identified additional
pathways that also appear to contribute to the regulation of
self-renewal of murine ES cells. Forced expression of homeodomain
protein Nanog can maintain ES cells in an undifferentiated
state in the absence of LIF (14, 15). The bone morphogenic
proteins BMP2 and BMP4 also participate in maintenance of
self-renewal by cooperating with LIF (16, 17). It appears that
BMP-induced expression of Id genes, via Smad signaling, suppresses
expression of genes, which normally induce neuronal
differentiation (16). Alternatively, it has also been reported
that BMP4-mediated inhibition of p38 MAPK activity may play
a role in regulation of self-renewal (17).
Other recent reports have implicated glycogen synthase 3
(GSK-3) ␣/␤ and the Wnt signaling pathway in regulation of
self-renewal of both murine and human ES cells (18, 19). This
work stemmed from the development of novel GSK-3 inhibitors
(18) although the selectivity of these novel inhibitors has not
been comprehensively evaluated (18). Additionally, Wnt3a has
been shown to play a role in maintaining self-renewal of hemopoietic
stem cells (20).
PI3Ks are a family of lipid kinases, whose products, phosphoinositide
3,4-bisphosphate (PI(3,4)P2) and phosphoinositide
3,4,5-trisphosphate (PI(3,4,5)P3) act as intracellular second
messengers (21, 22). Members of the three distinct classes of
PI3Ks have been implicated in the regulation of an array of
physiological processes, notably the control of proliferation, cell
survival, cell migration, and trafficking (21, 22). Members of
the class IA family of PI3Ks, comprising a regulatory subunit
(typically 85 or 55 kDa) and a 110 kDa catalytic subunit (21, 22)
are known to be activated via gp130, the signaling component
of the LIF receptor (23, 24). The role of phosphoinositide signaling
in ES cells is currently limited to reports implicating
PI3Ks in the control of ES cell proliferation (25–28). Here we
* This work was supported by the Biotechnology and Biological Sciences
Research Council and Wellcome Trust (to M. J. W.) and a Medical
Research Council research training fellowship (to H. W.). The costs of
publication of this article were defrayed in part by the payment of page
charges. This article must therefore be hereby marked “advertisement”
in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
‡ These authors contributed equally to this work.
§ Present address: Dept. of Biomedical Sciences, University of Ulster,
Colraine, NI.
¶ To whom correspondence should be addressed. Tel.: 44-1225-
386428; Fax: 44-1225-386114; E-mail: M.J.Welham@bath.ac.uk.
1
The abbreviations used are: LIF, leukemia inhibitory factor; BMP,
bone morphogenic protein; ERK, extracellular signal-regulated kinase;
ES, embryonic stem cell; GSK, glycogen synthase kinase; PI3K, phosphoinositide
3-kinase; PKB, protein kinase B; STAT, signal transducer
and activator of transcription; Tet, tetracycline; MAPK, mitogen-activated
protein kinase.
THE JOURNAL OF BIOLOGICAL CHEMISTRY Vol. 279, No. 46, Issue of November 12, pp. 48063–48070, 2004
© 2004 by The American Society for Biochemistry and Molecular Biology, Inc. Printed in U.S.A.
This paper is available on line at http://www.jbc.org 48063
at MASARYKOVA UNIVERZITA on July 23, 2013http://www.jbc.org/Downloaded from
report that PI3Ks are also involved in regulation of self-renewal
of murine ES cells. Using both pharmacological and
molecular tools we demonstrate that PI3K signaling is required
for efficient self-renewal in the presence of LIF. Loss of selfrenewal
upon inhibition of PI3K signaling is associated with an
increase in ERK phosphorylation, which appears to play a
functional role in this response.
EXPERIMENTAL PROCEDURES
Cell Culture and Generation of Transfectants—E14tg2a (4), CCE (29,
30), and IOUD2 (31) murine ES cell lines were routinely cultured on
tissue culture plates (Nunc) coated with 0.1% (v/v) porcine gelatin (Sigma)
in knock-out Dulbecco’s modified Eagle’s medium (Invitrogen, Scotland)
in the presence of 15% (v/v) knock-out serum replacement (Invitrogen),
0.1 mM mercaptoethanol, 1 mM sodium pyruvate, 2 mM glutamine, 0.1 mM
non-essential amino acids, and 500–1000 units/ml murine LIF (Chemicon).
Cells were trypsinized and replated or re-fed every second day. The
Tet-off-regulated expression system was used to express a dominant negative
p85 regulatory subunit of class IA PI3Ks. E14tg2a expressing the
Tet-sensitive transactivator, tTA (E14 tTA (32)), was a kind gift from Dr.
O. Witte (UCLA). 1 ϫ 107
E14 tTA cells were electroporated at 800 mV/3.0
microarad with 10 mg of linearized response plasmid encoding the dominant
negative form of class IA p85a regulatory subunit, termed ⌬p85.
⌬p85 lacks the p110 interaction site, so acting as a competitive inhibitor,
and we have described its use previously (33). Selection in the presence of
1000 units/ml LIF, 500 ng/ml Tet, and 200 mg/ml G418 was initiated 48 h
following transfection, and individual clones were picked following 6 days
in selection media. For screening, 1 ϫ 105
cells were plated into 60-mm
plates in the presence or absence of 500 ng/ml Tet. Following 24 h, lysates
were prepared and immunoblotted for expression of ⌬p85. Independent
clones (termed E14⌬p85) exhibiting very low to undetectable basal expression
and good inducible expression of ⌬p85 upon Tet removal were
selected for further analyses. For induction of expression of ⌬p85,
E14⌬p85 clones were washed three times with Hank’s-buffered saline
solution and then incubated in LIF-containing media in the absence of
Tet, to induce expression of ⌬p85, or were maintained in the presence of
500 ng/ml Tet for differing lengths of time, dependent on the experiment.
Self-renewal Assays—ES cells were plated at 3 ϫ 103
to 1 ϫ 104
cells
per gelatin-coated 60-mm tissue culture dish in Glasgow-modified Eagle’s
medium (Invitrogen) containing 10% (v/v) fetal bovine serum (EStested
Hyclone, Perbio, Cheshire, UK), 0.1 mM mercaptoethanol, 1 mM
sodium pyruvate, 2 mM glutamine, and 0.1 mM nonessential amino
acids. Plates were cultured without LIF or with the addition of LIF
(500–1000 units/ml depending on the experiment). E14tg2a, IOUD2, or
CCE cells were additionally supplemented with 5 ␮M LY294002, 10 ␮M
U0126, 50 ␮M PD98059, or Me2SO alone. Clones expressing ⌬p85 were
additionally plated in the presence or absence of 500 ng/ml Tet. To
detect cells expressing alkaline phosphatase, a marker of pluripotency,
after 3–6 days of culture, dishes for each treatment were washed, fixed,
and then stained for 15 min with a solution containing 1 mg/ml Fast
Red TR saltTM
(Sigma) dissolved in 0.1 M Tris, pH 9.2, containing 200
mg/ml naphthol AS-MX phosphate (34). Alkaline phosphatase-positive
colonies were counted in triplicate for each treatment.
Proliferation and Cell Viability Assays—XTT (sodium 3Ј-[1-[(phenylamino)-carbonyl]-3,4-tetrazolium]-bis(4-methoxy-6-nitro)
benzenesulfonic
acid hydrate) bioreduction assays were used to assess growth of
ES cells. 1 ϫ 103
ES cells were plated in triplicate in 96-well plates,
previously coated with 0.1% (w/v) gelatin in the presence or absence of
different doses of LY294002 (Calbiochem) or Me2SO alone in media
containing 1000 units/ml murine LIF. 25 ␮l of a solution containing 1
mg/ml XTT and 25 ␮M phenazine methosulfate was added per well for
the final 4 h of the 48-h incubation. The soluble formazan product was
measured at 450 nm. For cell growth curve analyses, cells were plated
at 1 ϫ 104
cells per 60-mm dish and counted in duplicate at defined
times. Viability was determined using trypan blue exclusion assays.
Duplicate plates were set up per treatment, and duplicate counts from
each plate performed.
Short Term Stimulations with LIF and Cell Lysates—ES cells and
transfectants were washed three times in Hank’s-buffered saline solution
and incubated for 4 h in media lacking serum replacement and LIF.
When required, 10 ␮M LY294002 or Me2SO alone were added for the
last 30 min of this preincubation period. Cells were stimulated for the
times indicated in minutes with 1 ϫ 104
units/ml LIF prior to preparation
of cell lysates. Dishes were placed on ice and washed three times
with ice-cold phosphate-buffered saline prior to lysis directly in the dish
with solubilization buffer, as described previously (35). Insoluble material
was removed by centrifugation for 3 min at full speed in a microcentrifuge
at 4 °C. Protein concentrations of clarified supernatants
were determined using the Bio-Rad protein assay kit according to the
manufacturers’ instructions.
Immunoblotting, Immunoprecipitation, and Antibodies—20 ␮g of
each cell lysate were fractionated by SDS-PAGE and immunoblotted
onto nitrocellulose (35). For immunoprecipitation, 500 ␮g of protein
were used per cell extract sample and anti-p85 precipitates prepared as
described previously (36). Primary antibodies were used at the following
dilutions for immunoblotting: 0.1 ␮g/ml mouse monoclonal antibody
recognizing phosphotyrosine 4G10 (Upstate Biotechnology, 05–321);
1:1000 for rabbit polyclonal antibodies recognizing dual phosphorylation
of ERK1 and 2 at Thr202
/Tyr204
(anti-pERK, Cell Signaling Technology
9101), phosphotyrosine 705 of STAT3 (anti-pSTAT3, CST 9131),
phosphoserine 473 of PKB (anti-pPKB, CST 9271), phosphoserines 21
or 9 of GSK-3␣/␤ (anti-pGSK3␣/␤, CST 9331), anti-phospho(Ser/
Thr)PKB substrate (anti-pPKBSub, CST 9611, which was used for
detection of phosphorylated S6 protein), phosphoserine 33/37 phosphothreonine
41 ␤-catenin (anti-p ␤-catenin, CST 9561), anti-pan ␤-catenin
(CST 9562), anti-pan PKB (CST 9272); 1:2000 anti-total ERK (panERK,
Santa Cruz Biotechnology, sc-93), anti-STAT3 (panSTAT3, sc-482), anti-STAT5
(sc-835), anti-SHP-1 (sc-287), anti-SHP-2 (sc 293), anti-Oct4
(sc-9081), and anti-p85 (Upstate Biotechnology, 06–195). Goat antirabbit
or goat anti-mouse secondary antibodies, conjugated to horseradish
peroxidase (Dako), were used at 1:10,000 dilution, and blots were
developed using ECL (Amersham Biosciences). Blots were stripped and
reprobed as described previously (37).
RESULTS
LIF Induces Activation of the PI3K Signaling Pathway—A
fundamental property of all stem cells is their ability to undergo
self-renewal. This process, defined as proliferation accompanied
by the suppression of differentiation, is essential for
maintenance of pluripotency (38). A thorough understanding of
the signals regulating stem cell fate is critical if the therapeutic
potential of embryonic and adult stem cells is to be fulfilled in
the future, and progress is being made toward this goal (5–
9,12,14–17,19). To expand our knowledge and understanding
of the signaling pathways regulating self-renewal of stem cells
we have investigated whether PI3K-dependent signaling, recently
implicated in the control of ES cell proliferation (25–28),
is also involved in control of murine ES cell self-renewal. Although
previous reports have demonstrated that gp130 receptors
couple to the PI3K pathway (10, 23), and that PI3K pathways
are active in ES cells (25, 26), the ability of LIF to directly
regulate this pathway in ES cells has not been reported.
We investigated LIF-induced activation of PI3K-dependent
signals by assessing phosphorylation of serine 473 on PKB
(also known as Akt), serine 21, or serine 9 of GSK3 ␣ and ␤, and
phosphorylation of the S6 protein. As shown in Fig. 1, A and B,
LIF treatment transiently increased phosphorylation of PKB/
Akt, GSK-3, and S6 protein. Interestingly, we did not detect
changes in phosphorylation of threonine 308 of PKB/Akt upon
LIF stimulation, the reasons for which are not clear (data not
shown). The dependence of these effects on PI3Ks were examined
by pretreating ES cells with the broad specificity PI3K
inhibitor, LY294002, an extremely useful and widely used tool
to investigate the involvement of PI3Ks in functional responses,
because it reversibly inhibits all three classes of PI3Ks
(39). As shown in Fig. 1A, LY294002 significantly reduces
LIF-induced phosphorylation of PKB, GSK-3, and S6 protein.
The class IA PI3K subfamily are most commonly activated by
cytokines signaling via gp130 (23, 24), and to examine their
role we expressed a Myc-tagged dominant negative version of
the p85␣ regulatory subunit of class IA PI3Ks in ES cells using
Tet-off-regulated expression. This mutant, termed ⌬p85, which
we have used successfully in the past (33, 40), lacks the p110
binding site (41) and acts as a competitive inhibitor for all class
IA catalytic subunits (p110 ␣, ␤, and ␦). A number of independent
E14tTA ES cell transfectants that expressed ⌬p85 in the
absence of Tet were isolated, characterized, and referred to as
E14⌬p85. Expression of ⌬p85 reduced phosphorylation of
PI3Ks Regulate Self-renewal of ES Cells48064
at MASARYKOVA UNIVERZITA on July 23, 2013http://www.jbc.org/Downloaded from
Ser473
of PKB/Akt, Ser21/9
of GSK-3␣/␤, and S6 proteins upon
LIF stimulation and in cells maintained in normal culture
conditions prior to lysis here termed Basal levels (ϪTet samples,
Fig. 1, B and C), although not to such an extent at
LY294002. As an additional measure of the coupling of LIF
signaling to the PI3K pathway, we performed immunoprecipitations
with antibodies recognizing the p85 adaptor subunit of
class IA family members. As shown in Fig. 1D, treatment of
E14tg2a ES cells with LIF led to increased co-precipitation of
endogenous p85 with a phosphotyrosyl-containing protein of
ϳ90–95 kDa, indicating engagement of the class IA PI3K pathway
upon LIF stimulation. These results, combined with the
ability of LIF to induce PI3K-dependent phosphorylation of
known downstream effectors, are consistent with LIF activating
the PI3K signal transduction cascade in undifferentiated
ES cells.
Inhibition of PI3K-dependent Signaling Reduces Murine ES
Cell Self-renewal—Given that LIF activates PI3K-dependent
signals, we investigated whether the PI3K pathway plays a
role in regulating self-renewal. Self-renewal was quantified
using clonal assays and staining for the presence of alkaline
phosphatase using Fast Red௢, which stains only undifferentiated
cells. Culturing E14tg2a ES cells in the presence of LIF
maintained undifferentiated colonies at between 80 and 90%
(Fig. 2A, panel i). Addition of 5 ␮M LY294002, a dose close to the
reported IC50 value for inhibition of class IA PI3Ks (39) but five
times lower than the dose used in previous studies on PI3K
action in ES cells (25), significantly reduced the proportion of
undifferentiated colonies observed in the presence of LIF (Fig.
2A, panel i). This effect was partially reversible because washout
of LY294002 after 24 or 48 h led to a partial recovery in
self-renewal (see Fig. 2A, panel ii). However, 24–48 h of incubation
with LY294002 was sufficient to result in commitment
of a proportion of the cells to differentiation. Similar results
were observed using IOUD2 ES cells, which are derived from
E14tg2a ES cells (31) and with a second independent ES cell
line, CCE (data not shown). In the absence of LIF, ES cells
spontaneously differentiated, and little effect of LY294002
treatment was noted. In LIF alone, largely spherical, alkaline
phosphatase-positive (red) colonies predominated. However,
with the addition of LY294002 the colonies formed were more
irregular and flattened appearance and with many fewer redstained
cells, highly suggestive of a more differentiated phenotype
(Fig. 2A, panel iii). With increased culture times, the
morphology of cells in the presence of LIF plus LY294002 began
to resemble cells from which LIF had been withdrawn (data not
shown).
Using the E14⌬p85 cell clones, we examined the effect expressing
⌬p85 on self-renewal. Induction of ⌬p85 expression by
removal of Tet, shown in Fig. 2B, panel ii, also significantly
reduced the ability of LIF to maintain self-renewal in three
independent clones tested, see Fig. 2B, panel i and induced a
similar change in morphology as LY294002 treatment, as
shown in Fig 2B, panel iii. The presence of Tet had no significant
effect on self-renewal of parental E14tTA cells (data not
shown). These results are consistent with PI3Ks, including the
class IA subfamily, playing a role in regulation of self-renewal
of murine ES cells.
Inhibition of PI3K Signaling Leads to Only Modest Effects on
ES Cell Survival and Proliferation—The change in cell morphology
that occurs following inhibition of PI3Ks is highly
suggestive of cells undergoing differentiation. However, while
undertaking this study, it was reported that PI3Ks play a role
in controlling proliferation of ES cells (25–27), with small alterations
in apoptosis also noted (25, 26). In our system, viability
in the presence of LIF after 4 days of incubation was, on
average 90.5% (Ϯ 1.5%) compared with 84.5% (Ϯ 0.5%) in the
presence of LIF plus 5 ␮M LY294002. In 2-day XTT-based
proliferation assays (Fig. 3A) it was only at doses of 10 ␮M and
above that LY294002 partially inhibited proliferation of
E14tg2a ES cells, consistent with the report where 25 ␮M
LY294002 was used (25). When we examined growth rates of
adherent cells in the presence and absence of LY294002 over
longer periods of time, LY294002 at 5 ␮M (the same dose we
FIG. 1. LIF-induced activation of PI3K-dependent signaling in
undifferentiated ES cells. A, E14tg2a ES cells were starved of LIF
and serum for 3.5 h and preincubated for 30 min with 10 ␮M LY294002
or Me2SO alone prior to stimulation with 1 ϫ 104
units/ml LIF for the
times indicated. B, E14⌬p85 ES cells were induced to express ⌬p85 by
the removal of tetracycline (ϪTet) for 24 h. As a control, cells were
maintained in the presence of Tet (ϩ Tet). After 24 h, cells were starved
of LIF and serum for 4 h prior to stimulation with 1 ϫ 104
units/ml LIF
for the times indicated. Basal refers to cells induced to express ⌬p85 for
24 h and used directly to prepare cell lysates, i.e. with no further
stimulation. C, E14⌬p85 ES cells were induced to express ⌬p85 by the
removal of tetracycline (ϪTet) for 24 h prior to preparation of cell
lysates. A–C, 20 ␮g of each protein sample were separated through 7.5%
or 10% acrylamide gels by SDS-PAGE, and immunoblotting was carried
out with the antibodies indicated (see “Experimental Procedures”). In A
and B duplicate blots were prepared and probed separately with either
anti-phospho-PKB substrate antibody or anti-phospho-GSK-3 antibody.
The same blots were stripped and reprobed with SHP-2 or p85 antibodies
to assess loading. A loading control for one set of samples is shown
in each case. D, E14tg2a ES cells were starved of LIF and serum for 4 h
prior to stimulation with 1 ϫ 104
units/ml LIF for 2 or 10 min or with
20%(v/v) serum (Ser) for 2 min. Precipitates were prepared with an
anti-p85 antibody, and after washing separated on a 7.5% acrylamide
gel. Immunoblotting was carried out first with the anti-phosphotyrosine
monoclonal antibody, 4G10 (␣-pY). The same immunoblot was
stripped and reprobed with the anti-p85 antibody. The two arrows on
the right hand side of the panel indicate the position of the phosphotyrosine-containing
proteins co-immunoprecipitating with p85 following
treatment with LIF or serum. Molecular mass standards are indicated
(in kDa) on the left side of the panel.
PI3Ks Regulate Self-renewal of ES Cells 48065
at MASARYKOVA UNIVERZITA on July 23, 2013http://www.jbc.org/Downloaded from
used for self-renewal assays) led to a small reduction in total
cell numbers (Fig. 3B) although rates of proliferation appeared
similar. Thus, our results are consistent with PI3K-dependent
signaling being required for efficient self-renewal of murine ES
cells, with only small effects on proliferation and apoptosis.
STAT3 Is Not a Target of PI3K Action—Our next aim was to
define the mechanisms involved in regulation of ES cell selfrenewal
by PI3Ks. The Oct-4 and STAT3 transcription factors
are known to be involved in maintenance of pluripotency (5–
8,42). Therefore, we first investigated whether the protein levels
of these factors were altered significantly in E14tg2a cells
treated with LY294002, compared with cells cultured in LIF
alone (Fig. 4A). The levels of Oct-4 and STAT3 were not altered
upon inclusion of LY294002. However, levels of STAT5 were
elevated in LY294002-treated cells. STAT5 has previously been
reported to be an early marker of ES cell differentiation (43)
FIG. 2. Inhibition of PI3Ks reduces
the ability of LIF to promote self-renewal.
A, panels i and ii, E14tg2a ES
cells were cultured in the presence or absence
of 1000 units/ml LIF in the presence
of 5 ␮M LY294002 or vehicle alone
(Me2SO, Ϫ) for the times indicated. In
panel ii, LY294002 was washed out after
24 or 48 h or maintained for the entire
culture period (144 h). Samples were fixed
and stained after 6 days in this analysis.
Triplicate counts were performed, and the
percentage of alkaline phosphatase (Fast
RedTM
)-positive colonies were determined
for each treatment. In panel i, a representative
experiment is shown, and S.D.
are included. Paired Student’s t tests
were performed, and the significance values
indicated by P. In panel ii, the combined
data of three independent experiments,
with S.E., are shown. Panel iii,
photographs of representative colonies
were taken on day 4 of the treatments
shown. The white bar represents 250 ␮m.
B, E14⌬p85 transfectants were incubated
in the presence of 500 ng/ml Tet (ϩ), or
without Tet (Ϫ), to induce expression of
⌬p85 in the presence of 500 units/ml LIF.
Panel i, 3 and 4 days after plating, colonies
were stained with alkaline phosphatase,
and triplicate counts performed. The
data represent the combined results, with
S.E. from at least four independent experiments
using three independent ⌬p85-expressing
clones. Panel ii, immunoblot
shows the levels of p85 and ⌬p85 expressed
by E14⌬p85 clone 4. ⌬p85 incorporates
a double Myc epitope tag, hence
its reduced migration through the gel.
Panel iii, photographs of representative
colonies were taken on day 4 of the treatments
shown. The white bar represents
250 ␮m.
PI3Ks Regulate Self-renewal of ES Cells48066
at MASARYKOVA UNIVERZITA on July 23, 2013http://www.jbc.org/Downloaded from
and this, coupled with the alteration in cell morphology is
consistent with the ES cells differentiating upon inhibition of
PI3Ks.
Previously, it has been proposed that the balance between
LIF-induced activation of STAT3 and ERKs may determine the
efficiency of self-renewal and hence stem cell fate (9, 13). Neither
pretreatment with LY294002 (Fig. 4B) nor expression of
⌬p85 (Fig. 4C) affected LIF-induced phosphorylation of STAT3
at tyrosine 705, the site important for STAT3 activation.
Inhibition of PI3K-dependent Signaling Increases Activation
of Erk MAP Kinases—We also examined the effect of PI3K
inhibition on phosphorylation of the MAP kinases ERK 1 and
ERK2 in response to LIF stimulation. Pretreatment with
LY294002 enhanced the ability of LIF to induce phosphorylation
of ERK1 and 2 in short term stimulation assays (Fig. 5A).
Expression of ⌬p85 also led to an increase in the level of ERK
phosphorylation observed in cells under basal conditions, i.e. in
the absence of acute treatment with LIF, as shown in Fig. 5B.
The increase in LIF-induced activation of ERK1 and 2 in the
presence of LY294002 prompted us to investigate whether this
alteration contributes functionally to the effects on self-renewal
we observe. Self-renewal assays were performed in the
presence of LIF with addition of either LY294002 alone (5 ␮M),
the MEK inhibitor U0126 alone (10 ␮M), or both inhibitors
together. As shown in Fig. 6A incubation with U0126 together
with LY294002 led to an increase in the percentage of alkaline
phosphatase-positive colonies compared with the effects of
LY294002 alone. The effect was dependent on the dose of
U0126, at 1 ␮M little effect was observed whereas 4 ␮M resulted
in a partial recovery at day 4 (data not shown). Similar results
were observed in the CCE ES cell line (data not shown). In such
longer term cultures of both E14tg2a and CCE, the presence of
U0126 reduced the increase in ERK phosphorylation caused by
incubation with LY294002, whereas the levels of STAT3 phosphorylation
were unaffected (see Fig. 6B). We also examined
the effects of MEK inhibitors, following expression of ⌬p85. The
two unrelated MEK inhibitors, PD98059 and U0126 both led to
FIG. 3. Inhibition of PI3Ks by LY294002 has only limited effects
on proliferation. A, E14tg2a parental ES cells were plated in
triplicate in gelatin-coated wells of a 96-well plate in media containing
1000 units/ml LIF. Different doses of LY294002 were added, or cells
were incubated with Me2SO alone. Plates were incubated at 37 °C for
48 h before being developed using XTT. Mean and S.D. are shown. B,
E14tg2a cells were plated at 1 ϫ 104
cells per 60-mm dish and incubated
with 1000 units/ml LIF, with or without addition of 5 ␮M LY294002. At
the times indicated, adherent cells were harvested and duplicate cell
counts performed, the average of which is shown.
FIG. 4. LY294002 pretreatment does not affect LIF-induced activation
of STAT3. A, E14tg2a ES cells were cultured in the presence of
1000 units/ml LIF in the presence of 5 ␮M LY294002 or vehicle alone
(Me2SO, Ϫ) for 3–5 days. B, E14tg2a ES cells were starved of LIF and
serum for 3.5 h and preincubated for 30 min with 10 ␮M LY294002 or
Me2SO alone prior to stimulation with 1 ϫ 104
units/ml LIF for the times
indicated. C, E14⌬p85 ES cells were induced to express ⌬p85 by the
removal of tetracycline (ϪTet) for 24 h. As a control, cells were maintained
in the presence of Tet (ϩTet). After 24 h, one sample for each condition
was lysed directly (Basal), and the remaining samples were starved of LIF
and serum for 4 h prior to stimulation with LIF as described in B. 20 ␮g
of each protein sample were separated through 7.5 or 10% acrylamide gels
by SDS-PAGE. A, immunoblotting was carried out with the antibodies
indicated. The anti-SHP-1 immunoblot shows equivalence of loading. B
and C, phosphorylation of STAT3 on tyrosine 705 was detected in the
upper panel (␣-pSTAT3). The blot was stripped and reprobed with an
antibody to detect total levels of STAT3 (␣-STAT3). In C a duplicate
immunoblot was probed with anti-p85 antibodies to illustrate levels of
⌬p85 expression achieved.
FIG. 5. Inhibition of PI3Ks enhances LIF-induced activation of
Erk MAPKs. A, E14tg2a were treated as described in the legend to Fig.
4B. B, E14⌬p85 ES cells were cultured in the presence (ϩ) or absence
(Ϫ) of Tet for 24 h prior to preparation of cell extracts. 20 ␮g of each
protein sample were separated through 10% acrylamide gels by SDSPAGE.
A and B, dual phosphorylation of the ERK activation motif was
detected (␣-pERK). The same immunoblot was stripped and reprobed to
detect total ERK protein (␣-ERK). In the case of B, this blot was
stripped again and reprobed with anti-p85 antibodies to illustrate the
levels of ⌬p85 expression achieved.
PI3Ks Regulate Self-renewal of ES Cells 48067
at MASARYKOVA UNIVERZITA on July 23, 2013http://www.jbc.org/Downloaded from
a recovery in self-renewal in cultures expressing ⌬p85, as
shown in Fig. 6C. Thus, regulation of ERK activity by PI3Kdependent
mechanisms at least partly contributes to determination
of stem cell self-renewal.
Effects of PI3K Inhibition on ␤-Catenin—Sato et al. (19)
recently reported that inhibition of GSK-3␤ enhances self-renewal
of murine and human ES cells, in part caused by maintenance
of ␤-catenin levels (19). Activation of PI3Ks leads to
PKB/Akt-dependent phosphorylation of GSK-3␣/␤ at serines 21
and 9, which inhibits GSK-3 activity. We predicted that if
␤-catenin-dependent events contribute to PI3K-dependent
maintenance of self-renewal, then inhibition of PI3Ks should
result in an increase in ␤-catenin phosphorylation at GSK-3
target sites coupled with a decrease in ␤-catenin levels, as a
result of enhanced ␤-catenin degradation. Our results, shown
in Fig. 7A, demonstrate that acute treatment with LIF did not
alter ␤-catenin phosphorylation at GSK-3␤-dependent sites or
levels of ␤-catenin and that treatment with LY294002 or expression
of ⌬p85 also had little influence. In long term cultures,
see Fig. 7B, ⌬p85 expression had little effect on ␤-catenin
phosphorylation or levels. However, we unexpectedly observed
a reduction in phosphorylation of ␤-catenin at Ser33
, Ser37
, and
Thr41
in cells treated with LY294002, although the overall
levels of ␤-catenin were not dramatically altered. LY294002
was effective over this time course, indicated by the consistent
reduction in phosphorylation of S6 protein phosphorylation
(Fig. 7B, left hand side, lower panels).
DISCUSSION
In this study we have characterized a role for PI3Ks in the
regulation of self-renewal of murine ES cells. We demonstrate
that LIF induces the PI3K-dependent phosphorylation of PKB/
Akt, GSK-3␣/␤, and S6 proteins. Uniquely, we show that inhibition
of PI3Ks with LY294002, for periods as short as 24 h,
results in a decline in the ability of murine ES cells to selfrenew.
The importance of PI3Ks in this response was confirmed
by the finding that expression of a dominant negative
form of the class I adaptor subunit p85, which more specifically
inhibits class IA PI3Ks (33, 40, 41), also led to a reduction in
self-renewal. Correspondingly, when PI3Ks were inhibited, ES
FIG. 6. Inhibition of MEKs reverses
the effect of inhibition of PI3Ks on ES
cell self-renewal. A and B, E14tg2a cells
were plated in the presence of 1000
units/ml LIF in the presence or absence of
5 ␮M LY294002 (LY), 10 ␮M U0126 (U0),
or both inhibitors together. Cultures were
incubated for 3–5 days. A, cultures were
stained using Fast RedTM
to detect alkaline
phosphatase-positive colonies. Cultures
were counted in triplicate, and the
percentage of alkaline phosphatase-positive
colonies determined. S.D. are shown
in each case. A representative experiment
is shown. B, cell lysates were prepared
from either E14tg2a or CCE ES cell cultures
at the times shown, and 20 ␮g separated
per sample through 10% acrylamide
gels by SDS-PAGE. Upper panel, dual
phosphorylation of the ERK activation
motif was detected (␣-pERK). The same
immunoblots were sequentially stripped
and reprobed to detect total ERK protein
(pan-ERK), phospho-STAT3 (␣-pSTAT3)
and total STAT3 (␣-STAT3), as indicated.
C, E14⌬p85 ES cells were incubated in
the presence of 500 units/ml LIF and in
the presence or absence of Tet to induce
expression of ⌬p85. Cells were additionally
plated in the presence or absence of
50 ␮M PD98059 (PD) or 10 ␮M U0126
(U0). Cultures were incubated for 4 days
and stained using Fast RedTM
to detect
alkaline phosphatase-positive colonies.
Cultures were counted in triplicate, and
the percentage of alkaline phosphatasepositive
colonies determined. The data
represent the combined results, with S.E.,
from two independent clones.
PI3Ks Regulate Self-renewal of ES Cells48068
at MASARYKOVA UNIVERZITA on July 23, 2013http://www.jbc.org/Downloaded from
cells adopted a more differentiated phenotype, and STAT5 expression
was elevated, consistent with commitment of the cells
to differentiation. Inhibition of PI3Ks also led to enhanced
LIF-induced activation of the ERK MAPKs, which appeared to
play a functional role because inhibition of ERK activity reversed
the effects of PI3K inhibition on self-renewal. Based on
these findings we propose that PI3Ks are important for maintenance
of efficient self-renewal of murine ES cells and when
inhibited cells commit to a program of differentiation.
PI3Ks have been implicated in the regulation of a plethora of
functional responses in a wide variety of cell systems including
migration, survival, cell cycle progression, and proliferation (22).
Previous studies examining the role of PI3K signaling in ES cells
have implicated PI3Ks in regulation of proliferation (25, 26),
possibly because PI3Ks operate downstream of ERas to promote
growth (27). At low doses of LY294002, we observed only small
effects on proliferation, although at doses of greater than 20 ␮M
our results are consistent with those published (25). We also
found that apoptosis only increased by ϳ6% upon inhibition of
PI3Ks, similar to levels previously reported (25, 26). We do not
believe that these small effects on viability and proliferation are
sufficient to account for the decline in self-renewal we report.
Whereas our findings may at first appear at odds with those of
Jirmanova et al. (25), we believe that they are consistent. IOUD2
ES cells, which express the neomycin resistance gene under the
regulation of the Oct-4 promoter (44), were used in the earlier
study, and only undifferentiated IOUD2 ES cells are resistant to
G418. When examining the effects of LY294002 on ES cell proliferation,
Jirmanova et al., maintained their IOUD2 cells in
G418, and under these conditions very little increase in cell
number was observed. Whereas this is consistent with reduced
proliferation, it is also consistent with the cells having differentiated,
so becoming susceptible to G418. In our studies,
LY294002 was effective in reducing self-renewal of IOUD2 ES
cells leading us to suggest that the effects previously attributed
to proliferation (25) are also consistent with PI3K signaling contributing
to efficient self-renewal.
In characterizing the mechanism of action of PI3Ks in regulation
of ES cell pluripotency we concentrated initially on
STAT3 and ERKs. Our data demonstrate an enhancement of
ERK 1 and 2 phosphorylation, consistent with their enhanced
activity upon inhibition of PI3Ks. The fact that inhibition of
MEK, an upstream regulator of the ERK cascade by two structurally
unrelated MEK inhibitors, overcomes the effects of
PI3K inhibition on self-renewal argues in favor of this effect
being functionally important. Based on these results, we propose
that upon PI3K inhibition, the balance between STAT-3
and ERK signals, believed to be important in determining cell
fate (13), is altered in favor of the prodifferentiation effects of
the ERK cascade. It is interesting that a recent report demonstrating
a role for BMP4 in maintenance of self-renewal of
murine ES cells implicated BMP4-induced inhibition of p38
and ERK MAPKs in the response (17). Others have reported
elevated ERK activation in ES cells lacking the p85␣ regulatory
subunit of class IA PI3Ks compared with their wild-type
counterparts in response to IGF-1 (26). ES cells lacking functional
phosphoinositide-dependent kinase 1, a downstream effector
of PI3Ks, also have elevated levels of basal ERK activity,
which increases further after treatment with LY294002 (45).
These two reports, along with our study, are consistent with
PI3Ks playing a role in negative regulation of ERK activity in
ES cells. This is distinct from findings in many terminally
differentiated cells, where inhibition of PI3K activity results in
reduced activation of the ERKs (40, 46). Importantly, in differentiated
myotubes PKB/Akt negatively regulates the RafMEK-ERK
pathway via actions on Raf (47). One intriguing
possibility is that similar mechanisms of cross-talk may be
active in murine ES cells and contribute to determination of
cell fate.
While our data support a functional role for ERKs in the PI3K
dependence of self-renewal, we cannot rule out the possibility
that PI3K signaling also regulates additional pathways. BMP2/4
signaling via Smads, leading to increased expression of the Id
transcriptional repressors, contributes to maintenance of selfFIG.
7. Inhibition of PI3Ks does not dramatically alter ␤-catenin phosphorylation or levels. A, E14tg2a ES cells (left hand panel) and
E14⌬p85 ES cells (right hand panel) treated as described in the legend to Fig. 1 (A and B). B, cell lysates were prepared from E14tg2a (left hand
panel) incubated in the absence or presence of 5 ␮M LY294002 for 4–6 days or E14⌬p85 ES cells (right hand panel) that had been induced to express
⌬p85 by the removal of tetracycline (ϪTet) for the times shown or maintained in Tet as a control. 20 ␮g of each protein sample were separated
through either 7.5% (for anti-␤-catenin blots) or 10% (for anti-pPKBsub blotting) acrylamide gels by SDS-PAGE. Immunoblotting was carried out
first with antibody specific for ␤-catenin phosphorylated at serines 33 and 37 and threonine 41. Blots were stripped and reprobed with anti-pan
␤-catenin antibody and then stripped again and probed with either SHP-2 or p85 antibodies to assess equivalence of loading and expression of
⌬p85. Immunoblotting of the same samples shown in B (left hand panel) with the pPKBsub antibody was used to the demonstrate the sustained
inhibitory effect of LY294002 over the time course.
PI3Ks Regulate Self-renewal of ES Cells 48069
at MASARYKOVA UNIVERZITA on July 23, 2013http://www.jbc.org/Downloaded from
renewal by effectively blocking differentiation to neuronal lineages
(16). Recent reports suggest that members of the TGF-␤
family, including BMP2, can activate PI3K-dependent signaling
in certain cell systems (48–50). In addition, these reports suggest
that PI3K-dependent pathways are involved in regulation of
Smad protein transcriptional activity, either via modulation of
phosphorylation or location (48–50). Therefore, it will be interesting
to address whether PI3Ks regulate BMP2/4 activation of
Smads in murine ES cells, which could also contribute to their
role in regulating self-renewal.
Sato et al. (19) have reported that the GSK-3␤ inhibitor
termed BIO maintains self-renewal of murine ES cells in the
absence of LIF, implicating the canonical Wnt/␤-catenin signaling
in maintenance of self-renewal. If PI3Ks also acted via
effects on this pathway then we would have expected to measure
alterations in ␤-catenin phosphorylation and levels, but we
did not. Therefore, our results suggest that PI3K-dependent
regulation of self-renewal occurs independently of effects on
␤-catenin. However, it is possible that BIO mimics the effects of
PI3K activation, by inhibiting GSK-3 activity, and contributes
to self-renewal via pathways not involving Wnt/␤-catenin. Additional
experimentation is required to further define the mode
of action of BIO.
Based on our studies we propose that PI3K-dependent signaling
is required for efficient self-renewal of murine ES cells,
and regulation of ERK activity is functionally important in this
response. Further investigations should reveal how PI3K inhibition
alters the genetic program of undifferentiated ES cells
thereby leading to loss of self-renewal. It will also be interesting
to evaluate if PI3K-dependent signaling is important for
self-renewal of human ES cells.
Acknowledgments—We thank Owen Witte (UCLA) for the E14tg2a
cells expressing tTA and Austin Smith (ISCR, University of Edinburgh,
Scotland) for IOUD2 ES cells.
REFERENCES
1. Evans, M. J., and Kaufmann, M. (1981) Nature 292, 154–156
2. Martin, G. R. (1981) Proc. Natl. Acad. Sci. U. S. A. 78, 7634–7638
3. Smith, A. G., Heath, J. K., Donaldson, D. D., Wong, G. G., Moreau, J., Stahl,
M., and Rogers, D. (1988) Nature 336, 688–690
4. Smith, A. G., and Hooper, M. L. (1987) Dev. Biol. 121, 1–9
5. Boeuf, H., Hauss, C., DeGraeve, F., Baran, N., and Kedinger, C. (1997) J. Cell
Biol. 138, 1207–1217
6. Matsuda, T., Nakamura, T., Nakao, K., Arai, T., Katsuki, M., Heike, T., and
Yokota, T. (1999) EMBO J. 18, 4261–4269
7. Niwa, H., Burdon, T., Chambers, I., and Smith, A. (1998) Genes Dev. 12,
2048–2060
8. Raz, R., Lee, C. K., Cannizzaro, L. A., D’Eustachio, P., and Levy, D. E. (1999)
Proc. Natl. Acad. Sci. U. S. A. 96, 2846–2851
9. Burdon, T., Stracey, C., Chambers, I., Nichols, J., and Smith, A. (1999) Dev.
Biol. 210, 30–43
10. Ernst, M., Oates, A., and Dunn, A. R. (1996) J. Biol. Chem. 271, 30136–30143
11. Boeuf, H., Merienne, K., Jacquot, S., Duval, D., Zeniou, M., Hauss, C.,
Reinhardt, B., Huss-Garcia, Y., Dierich, A., Frank, D. A., Hanauer, A., and
Kedinger, C. (2001) J. Biol. Chem. 276, 46204–46211
12. Anneren, C., Cowan, C. A., and Melton, D. A. (2004) J. Biol. Chem. 279,
31590–31598
13. Burdon, T., Smith, A., and Savatier, P. (2002) Trends in Cell Biol. 12, 432–438
14. Mitsui, K., Tokuzawa, Y., Itoh, H., Segawa, K., Murakami, M., Takahashi, K.,
Maruyama, M., Maeda, M., and Yamanaka, S. (2003) Cell 113, 631–642
15. Chambers, I., Colby, D., Robertson, M., Nichols, J., Lee, S., Tweedie, S., and
Smith, A. (2003) Cell 113, 643–655
16. Ying, Q. L., Nichols, J., Chambers, I., and Smith, A. (2003) Cell 115, 281–292
17. Qi, X., Li, T.-G., Hao, J., Hu, J., Wang, J., Simmons, H., Miura, S., Mishina, Y.,
and Zhao, G.-Q. (2004) Proc. Natl. Acad. Sci, U. S. A. 101, 6027–6032
18. Meijer, L., Skaltsounis, A.-L., Magiatis, P., Polychronopoulus, P., Knockaert,
M., Leost, M., Ryan, X. P., Vonica, C. A., Brivanlou, A. H., Dajani, R.,
Crovace, C., Tarricone, C., Musacchio, A., Trose, S. M., Pearl, L., and
Greengard, P. (2003) Chem. Biol. 10, 1255–1266
19. Sato, N., Meijer, L., Skaltsounis, L., Greengard, P., and Brivanlou, A. H. (2004)
Nat. Med. 10, 55–63
20. Reya, T., Duncan, A. W., Allies, L., Doman, J., Scherer, D. C., Wilert, K., Hinta,
L., Nusse, R., and Weissman, I. L. (2003) Nature 423, 409–414
21. Vanhaesebroeck, B., and Waterfield, M. D. (1999) Exp. Cell Res. 253, 239–254
22. Vanhaesebroeck, B., Leevers, S. J., Ahmadi, K., Timms, J., Katso, R., Driscoll,
P. C., Woscholski, R., Parker, P. J., and Waterfield, M. D. (2001) Annu. Rev.
Biochem. 70, 535–602
23. Boulton, T. G., Stahl, N., and Yancopoulos, G. D. (1994) J. Biol. Chem. 269,
11648–11655
24. Takahashi-Tezuka, M., Yoshida, Y., Fukada, T., Ohtani, T., Yamanaka, Y.,
Nishida, K., Nakajima, K., Hibi, M., and Hirano, T. (1998) Mol. Cell. Biol.
18, 4109–4117
25. Jirmanova, L., Afanassieff, M., Gobert-Gosse, S., Markossian, S., and Savatier,
P. (2002) Oncogene 21, 5515–5528
26. Hallmann, D., Trumper, K., Trusheim, H., Ueki, K., Kahn, R., Cantley, L. C.,
Fruman, D. A., and Horsch, D. (2003) J. Biol. Chem. 278, 5099–5108
27. Takahashi, K., Mitsui, K., and Yamanaka, S. (2003) Nature 423, 541–545
28. Sun, H., Lesche, R., Li, D. M., Liliental, J., Zhang, H., Gao, J., Gavrilova, N.,
Mueller, B., Liu, X., and Wu, H. (1999) Proc. Natl. Acad. Sci. U. S. A. 96,
6199–6204
29. Keller, G., Kennedy, M., Papayannopoulou, T., and Wiles, M. V. (1993) Mol.
Cell. Biol. 13, 473–486
30. Robertson, E., Bradley, A., Kuehn, M., and Evans, M. (1986) Nature 323,
445–448
31. Dani, C., Chambers, I., Johnstone, S., Robertson, M., Ebrahimi, B., Saito, M.,
Taga, T., Li, M., Burdon, T., Nichols, J., and Smith, A. (1998) Dev. Biol. 203,
149–162
32. Era, T., and Witte, O. N. (2000) Proc. Natl. Acad. Sci. U. S. A. 97, 1737–1742
33. Craddock, B. L., Orchiston, E. A., Hinton, H. J., and Welham, M. J. (1999)
J. Biol. Chem. 274, 10633–10640
34. Scutt, A., and Bertram, P. (1999) Calc. Tiss. Intl. 64, 69–77
35. Welham, M. J., Duronio, V., Leslie, K. B., Bowtell, D., and Schrader, J. W.
(1994) J. Biol. Chem. 269, 21165–21176
36. Craddock, B. L., and Welham, M. J. (1997) J. Biol. Chem. 272, 29281–29289
37. Welham, M. J., Dechert, U., Leslie, K. B., Jirik, F., and Schrader, J. W. (1994)
J. Biol. Chem. 269, 23764–23768
38. Smith, A. G. (2001) Annu. Rev. Cell Dev. Biol. 17, 435–462
39. Vlahos, C. J., Matter, W. F., Hui, K. Y., and Brown, R. F. (1994) J. Biol. Chem.
269, 5241–5248
40. Craddock, B. L., Hobbs, J., Edmead, C., and Welham, M. J. (2001) J. Biol.
Chem. 276, 24274–24283
41. Hara, K., Yonezawa, K., Sakaue, H., Ando, A., Kotani, K., Kitamura, T.,
Kitamura, Y., Ueda, H., Stephens, L., Jackson, T. R., Hawkins, P. T.,
Dhand, R., Clark, A. E., Holman, G. D., Waterfield, M. D., and Kasuga, M.
(1994) Proc. Natl. Acad. Sci. U. S. A. 91, 7415–7419
42. Niwa, H., Miyazaki, J., and Smith, A. G. (2000) Nat. Gen. 24, 372–376
43. Nemetz, C., and Hocke, G. M. (1998) Differentiation 62, 213–220
44. Mountford, P., Zevnik, B., Duwel, A., Nichols, J., Li, M., Dani, C., Robertson,
M., Chambers, I., and Smith, A. (1994) Proc. Natl. Acad. Sci. U. S. A. 91,
4303–4307
45. Williams, M. R., Arthur, J. S. C., Balendran, A., van der Kaay, J., Poli, V.,
Cohen, P., and Alessi, D. R. (2000) Curr. Biol. 10, 439–448
46. Wennstrom, S., and Downward, J. (1999) Mol. Cell. Biol. 19, 4279–4288
47. Rommel, C., Clarke, B. A., Zimermann, S., Nunez, L., Rossman, R., Reid, K.,
Moelling, K., Yancopoulos, G. D., and Glass, D. J. (1999) Science 286,
1738–1741
48. Bakin, A. V., Tomlinson, A. K., Bhowmick, N. A., Moses, H. L., and Arteaga,
C. L. (2000) J. Biol. Chem. 275, 36803–36810
49. Ghosh-Choudhury, N., S. L., A., Nishimura, R., Celeste, A., Mahimainathan,
L., and Ghosh-Choudhury, G. (2002) J. Biol. Chem. 277, 33361–33368
50. Runyan, C. E., Schnaper, H. W., and Poncelet, A. C. (2004) J. Biol. Chem. 279,
2632–2639
PI3Ks Regulate Self-renewal of ES Cells48070
at MASARYKOVA UNIVERZITA on July 23, 2013http://www.jbc.org/Downloaded from